Health condition
Acromegaly remission monitoring
After treatment for acromegaly, lifelong monitoring of IGF-1 and growth hormone confirms remission, detects recurrence early, and tracks the complications - joints, heart, glucose and bowel - that need ongoing care.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Remission is defined biochemically: a normal age-adjusted IGF-1, with growth hormone suppressing on glucose testing where needed
-
IGF-1 is checked around 12 weeks after surgery, then at least annually for life
-
MRI surveillance watches any residual tumour; recurrence can occur years later
-
Complication care continues in remission: blood pressure, glucose, sleep apnoea, joints and colonoscopy per guidance
-
Pituitary function is reviewed after surgery or radiotherapy, as new deficiencies can develop over time
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
Treating the tumour is the beginning, not the end. Surgery cures many, but residual cells can reactivate a decade later; radiotherapy takes years to work and slowly switches off healthy pituitary function while it does; medication controls rather than cures. Meanwhile the body carries acromegaly's footprint - arthropathy, sleep apnoea, cardiomyopathy, glucose intolerance and an increased tendency to bowel polyps - which improves with biochemical control but still needs watching.
Diagnosis and treatment routes
A sensible surveillance package pairs annual IGF-1 (with glucose-suppressed growth hormone when results are equivocal) and periodic MRI with structured complication review: blood pressure, HbA1c, sleep assessment, echocardiography where indicated and colonoscopy at guideline intervals, plus checks for evolving hypopituitarism after radiotherapy. If your follow-up has lapsed - which is common when care transfers between hospitals - re-establishing it matters; a private endocrinologist can typically review your remission status within about two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant endocrinologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about Acromegaly remission monitoring.
Quick, plain-English answers to what people ask us most.
-
What does remission monitoring in acromegaly involve?
Remission monitoring involves regular blood tests to check growth hormone and IGF-1 levels, along with periodic pituitary imaging and assessment of related complications, to confirm the condition remains controlled after treatment.
-
Why is ongoing monitoring needed after acromegaly treatment?
Even after successful surgery, medication, or radiotherapy, hormone levels can fluctuate or the tumour can regrow, so lifelong monitoring helps catch any recurrence early and ensures related complications are managed.
-
What tests are used to monitor acromegaly remission?
The main tests are IGF-1 blood levels and sometimes an oral glucose tolerance test to check growth hormone suppression, alongside MRI scans of the pituitary gland at intervals determined by your specialist.
-
Is it dangerous if acromegaly isn't fully controlled?
Yes, incompletely controlled acromegaly continues to carry increased risks of cardiovascular disease, diabetes, and joint damage, so achieving and maintaining true biochemical remission is an important treatment goal.
-
Can acromegaly relapse after apparent remission?
Yes, relapse can occur, particularly if a tumour was only partially removed, which is why regular monitoring continues even years after apparently successful treatment.
-
How often is monitoring needed once in remission?
Typically, monitoring occurs every six to twelve months once stable remission is confirmed, though frequency may be higher in the first year or two after treatment or if any test results are borderline.
-
How long does it take to confirm true remission?
Confirming stable remission usually takes at least three to six months after treatment, since hormone levels need time to settle before results reliably reflect the true post-treatment state.
-
Remission monitoring vs initial diagnostic testing — what's the difference?
Initial diagnosis focuses on confirming excess growth hormone and identifying the pituitary tumour, while remission monitoring focuses on tracking hormone levels and imaging over time to detect any recurrence after treatment has been given.
-
What happens if monitoring shows the condition isn't controlled?
If tests suggest ongoing or recurrent excess hormone, options include adjusting or adding medication, considering further surgery, or radiotherapy, depending on individual circumstances and tumour characteristics.
-
When should I discuss my monitoring plan, and how quickly can I be seen privately?
Discuss monitoring frequency with your endocrinologist at each review. NHS follow-up intervals are typically set by the treating team, while private endocrinology review can usually be arranged within about two weeks if you have concerns between appointments.